Active ingredients: ranitidine
The Therapeutic Goods Administration (TGA) has a recall notice on this product.
The Therapeutic Goods Administration (TGA) has issued an alert on ranitidine. For more information and the latest updates, see TGA's alert on ranitidine.
What it is used for
Short-term treatment of proven duodenal ulcer and gastric ulcer. Maintenance treatment to reduce the risk of relapse in duodenal ulcer. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer. Treatment of gastrinoma (Zollinger-Ellison syndrome). Short-term symptomatic treatment of reflux oesophagitis, unresponsive to conservative antireflux measures and simple drug therapies such as antacids. Maintenance treatment to reduce risk of relapse of reflux oesophagitis. Treatment of scleroderma oesophagitis.
How to take it
The way to take this medicine is: Oral. This medicine is taken by mouth.
- Store below 25 degrees Celsius
- Protect from Light
- Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
White film coated round tablet, embossed with "150" on one side and plain on the other.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient ranitidine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems